← Back to headlines
Japan Approves Insurance Coverage for iPS Cell Therapy for Parkinson's Disease
Japan's Central Social Insurance Medical Council has approved health insurance coverage for 'Amshepuru,' an iPS cell-based regenerative medicine product for Parkinson's disease treatment. The cost for a single treatment is set at approximately 55.3 million yen.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
